共 50 条
- [42] What to evaluate in prevention outcomes: Effectiveness, Cost-benefits, Cost-savings, Equity EPIDEMIOLOGIA & PREVENZIONE, 2018, 42 (5-6): : 372 - 375
- [45] Group psychedelic therapy: empirical estimates of cost-savings and improved access FRONTIERS IN PSYCHIATRY, 2023, 14
- [50] Azasan® -: Branded generic azathioprine:: Substantial cost-savings potential in IBD AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S225 - S225